JULIA WAMBOLT: Open Payments
NPI 1346951076 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 18 payments from 10 companies in 2025. Trend: 2023 $117 · 2024 $222 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $171 |
| SHIELD THERAPEUTICS INC | 2 | $116 |
| Lilly USA, LLC | 1 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $35 |
| Sage Therapeutics, LLC | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| MILLICENT US INC | 2 | $30 |
| Exeltis, USA Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Veozah, ACCRUFER, ZEPBOUND, ZURZUVAE, FEMLYV, SLYND, LILETTA, MYFEMBREE.
Industry payments across OK — which companies pay providers there.
